Anne Moore has more than 15 years of experience in and investment banking dedicated to Healthcare and Life Sciences. She served as VP of Strategy for a Nasdaq/Euronext CAR-T clinical-stage biotech, bringing the industry’s view to the table to ensure all recommendations are actionable and that business sense is driving the project.

Her competencies include growth strategy, product launch and life cycle management, current and future trend analysis, M&A strategy and due diligence. She led numerous equity financings and strategic engagements for clients across Europe and the United States.

She has advised and accompanied all types of businesses, from small start-ups to major global pharma and investment funds, as well as non-profits. Having spent her life between the US and Europe, she has a particular sensitivity to cultural differences and knows how to navigate international contexts.

Anne holds a PhD in Human Genetics and Physiology from the Paris XII University and an Advanced Master's in Biotechnology Management from Toulouse Business School. She worked in the US, as well as in France and Belgium. She is bilingual in English and French.